Filing Details

Accession Number:
0001840315-23-000007
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-12-07 21:21:38
Reporting Period:
2023-12-05
Accepted Time:
2023-12-07 21:21:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1314102 Eyepoint Pharmaceuticals Inc. EYEP Laboratory Analytical Instruments (3826) 262774444
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1840315 Therapeutics Ocumension 56F, One Museum Place
669 Xin Zha Road
Jing'An District, Shanghai F4 200041
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-12-05 733,758 $19.91 2,276,963 No 4 S Direct
Common Stock Disposition 2023-12-06 266,242 $18.41 2,010,721 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct